Historical record - last NADAC effective date: 8/21/2024
Product Information
TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB is a generic product labeled by BluePoint Laboratories, priced at $0.0963 per EA under NDC 68001038703. Its NADAC has been published 225 times since May 13, 2020.
FDA first approved this application on Sep 23, 1993. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25; 37.5 mg/1; mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001038703
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/21/2024
Active Ingredients
HYDROCHLOROTHIAZIDE; TRIAMTERENEApproval Type
Generic (ANDA)
FDA Application
ANDA073449FDA Approved
9/23/1993
TE Code
AB
On Market Since
6/18/2019
Pharmacological Classes
Price Statistics
The NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB has been published 225 times since May 13, 2020, and over the history we have for it it has declined 9.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0963 per EA |
|---|---|
| All-time high | $0.1187 (Aug 11, 2021) |
| All-time low | $0.0794 (Apr 17, 2024) |
| Median price | $0.0979 |
| Average price | $0.0984 |
| Largest weekly change | +23.5% (Jun 19, 2024) |
| Weeks tracked | 225 |
| Tracking since | May 13, 2020 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+3.3%
5Y
-9.6%
All
-9.4%
Last surveyed Aug 28, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB, manufactured by BluePoint Laboratories, is $0.0963 per EA (NDC 68001038703), effective Aug 28, 2024.
How has the price of TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB changed over time?
Over the history we have for it, the NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB has declined 9.4%. It has been tracked across 225 weekly CMS publications since May 13, 2020.
What are the highest and lowest recorded NADAC prices for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB?
Since May 13, 2020, the NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB has ranged from a low of $0.0794 (Apr 17, 2024) to a high of $0.1187 (Aug 11, 2021), with a median of $0.0979 per EA.
Are there cheaper alternatives to TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB in a comparable dosage form, but none are currently priced below it.
Who manufactures TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB?
TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB (NDC 68001038703) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.